nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—HTR2A—myenteric nerve plexus—stomach cancer	0.017	0.27	CbGeAlD
Methylergometrine—Thrombophlebitis—Floxuridine—stomach cancer	0.0152	0.0371	CcSEcCtD
Methylergometrine—Vasospasm—Capecitabine—stomach cancer	0.0121	0.0295	CcSEcCtD
Methylergometrine—Thrombophlebitis—Mitomycin—stomach cancer	0.0119	0.0291	CcSEcCtD
Methylergometrine—HTR2A—vagus nerve—stomach cancer	0.0113	0.18	CbGeAlD
Methylergometrine—Angina pectoris—Floxuridine—stomach cancer	0.0111	0.027	CcSEcCtD
Methylergometrine—HTR2A—vein—stomach cancer	0.0109	0.174	CbGeAlD
Methylergometrine—Muscle spasms—Floxuridine—stomach cancer	0.00761	0.0186	CcSEcCtD
Methylergometrine—Anaphylactic shock—Floxuridine—stomach cancer	0.00646	0.0158	CcSEcCtD
Methylergometrine—Nervous system disorder—Floxuridine—stomach cancer	0.00634	0.0155	CcSEcCtD
Methylergometrine—Ventricular fibrillation—Capecitabine—stomach cancer	0.0054	0.0132	CcSEcCtD
Methylergometrine—Hypertension—Mitomycin—stomach cancer	0.00536	0.0131	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Floxuridine—stomach cancer	0.00528	0.0129	CcSEcCtD
Methylergometrine—Thrombophlebitis—Irinotecan—stomach cancer	0.00518	0.0126	CcSEcCtD
Methylergometrine—Abdominal pain—Floxuridine—stomach cancer	0.00511	0.0125	CcSEcCtD
Methylergometrine—Thrombophlebitis—Fluorouracil—stomach cancer	0.00496	0.0121	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Irinotecan—stomach cancer	0.00457	0.0112	CcSEcCtD
Methylergometrine—Dyspnoea—Mitomycin—stomach cancer	0.00452	0.011	CcSEcCtD
Methylergometrine—Diarrhoea—Floxuridine—stomach cancer	0.00442	0.0108	CcSEcCtD
Methylergometrine—Methysergide—HTR1A—stomach cancer	0.00434	0.167	CrCbGaD
Methylergometrine—Vomiting—Floxuridine—stomach cancer	0.00411	0.01	CcSEcCtD
Methylergometrine—Rash—Floxuridine—stomach cancer	0.00408	0.00995	CcSEcCtD
Methylergometrine—Dermatitis—Floxuridine—stomach cancer	0.00407	0.00994	CcSEcCtD
Methylergometrine—Headache—Floxuridine—stomach cancer	0.00405	0.00988	CcSEcCtD
Methylergometrine—Pergolide—HTR1A—stomach cancer	0.00402	0.155	CrCbGaD
Methylergometrine—Lisuride—ADRB1—stomach cancer	0.0039	0.15	CrCbGaD
Methylergometrine—Nausea—Floxuridine—stomach cancer	0.00384	0.00937	CcSEcCtD
Methylergometrine—Angina pectoris—Irinotecan—stomach cancer	0.00377	0.00921	CcSEcCtD
Methylergometrine—Sweating increased—Irinotecan—stomach cancer	0.00377	0.00921	CcSEcCtD
Methylergometrine—Angina pectoris—Fluorouracil—stomach cancer	0.00361	0.00882	CcSEcCtD
Methylergometrine—Bromocriptine—ADRB1—stomach cancer	0.00361	0.139	CrCbGaD
Methylergometrine—Thrombophlebitis—Docetaxel—stomach cancer	0.00358	0.00873	CcSEcCtD
Methylergometrine—Lisuride—HTR1A—stomach cancer	0.00349	0.134	CrCbGaD
Methylergometrine—HTR2A—blood vessel—stomach cancer	0.00347	0.0553	CbGeAlD
Methylergometrine—Diarrhoea—Mitomycin—stomach cancer	0.00347	0.00847	CcSEcCtD
Methylergometrine—Thrombophlebitis—Capecitabine—stomach cancer	0.00346	0.00846	CcSEcCtD
Methylergometrine—Dizziness—Mitomycin—stomach cancer	0.00335	0.00818	CcSEcCtD
Methylergometrine—Ergotamine—HTR1A—stomach cancer	0.00335	0.129	CrCbGaD
Methylergometrine—Bromocriptine—HTR1A—stomach cancer	0.00323	0.125	CrCbGaD
Methylergometrine—Vomiting—Mitomycin—stomach cancer	0.00322	0.00787	CcSEcCtD
Methylergometrine—Rash—Mitomycin—stomach cancer	0.0032	0.0078	CcSEcCtD
Methylergometrine—Dermatitis—Mitomycin—stomach cancer	0.00319	0.0078	CcSEcCtD
Methylergometrine—Headache—Mitomycin—stomach cancer	0.00318	0.00775	CcSEcCtD
Methylergometrine—Bradycardia—Irinotecan—stomach cancer	0.00316	0.0077	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Capecitabine—stomach cancer	0.00306	0.00747	CcSEcCtD
Methylergometrine—HTR2B—smooth muscle tissue—stomach cancer	0.00305	0.0486	CbGeAlD
Methylergometrine—Nausea—Mitomycin—stomach cancer	0.00301	0.00735	CcSEcCtD
Methylergometrine—Atrioventricular block—Epirubicin—stomach cancer	0.00297	0.00724	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Epirubicin—stomach cancer	0.00288	0.00703	CcSEcCtD
Methylergometrine—Cardiac disorder—Irinotecan—stomach cancer	0.00288	0.00702	CcSEcCtD
Methylergometrine—Atrioventricular block—Doxorubicin—stomach cancer	0.00275	0.0067	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Doxorubicin—stomach cancer	0.00266	0.0065	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Epirubicin—stomach cancer	0.00264	0.00645	CcSEcCtD
Methylergometrine—Angina pectoris—Docetaxel—stomach cancer	0.00261	0.00636	CcSEcCtD
Methylergometrine—Muscle spasms—Irinotecan—stomach cancer	0.00259	0.00633	CcSEcCtD
Methylergometrine—Thrombophlebitis—Methotrexate—stomach cancer	0.00258	0.00629	CcSEcCtD
Methylergometrine—Sweating increased—Capecitabine—stomach cancer	0.00253	0.00616	CcSEcCtD
Methylergometrine—Angina pectoris—Capecitabine—stomach cancer	0.00253	0.00616	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Doxorubicin—stomach cancer	0.00245	0.00597	CcSEcCtD
Methylergometrine—Thrombophlebitis—Epirubicin—stomach cancer	0.00241	0.00589	CcSEcCtD
Methylergometrine—HTR2B—digestive system—stomach cancer	0.00241	0.0383	CbGeAlD
Methylergometrine—Hypertension—Irinotecan—stomach cancer	0.00233	0.00569	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Methotrexate—stomach cancer	0.00228	0.00556	CcSEcCtD
Methylergometrine—Convulsion—Fluorouracil—stomach cancer	0.00224	0.00547	CcSEcCtD
Methylergometrine—Thrombophlebitis—Doxorubicin—stomach cancer	0.00223	0.00545	CcSEcCtD
Methylergometrine—Haematuria—Capecitabine—stomach cancer	0.0022	0.00538	CcSEcCtD
Methylergometrine—Anaphylactic shock—Irinotecan—stomach cancer	0.0022	0.00538	CcSEcCtD
Methylergometrine—Chest pain—Fluorouracil—stomach cancer	0.0022	0.00537	CcSEcCtD
Methylergometrine—Nervous system disorder—Irinotecan—stomach cancer	0.00216	0.00527	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Epirubicin—stomach cancer	0.00213	0.0052	CcSEcCtD
Methylergometrine—Hyperhidrosis—Irinotecan—stomach cancer	0.00213	0.0052	CcSEcCtD
Methylergometrine—Bradycardia—Capecitabine—stomach cancer	0.00211	0.00515	CcSEcCtD
Methylergometrine—Anaphylactic shock—Fluorouracil—stomach cancer	0.00211	0.00515	CcSEcCtD
Methylergometrine—Nervous system disorder—Fluorouracil—stomach cancer	0.00207	0.00505	CcSEcCtD
Methylergometrine—Tachycardia—Fluorouracil—stomach cancer	0.00206	0.00502	CcSEcCtD
Methylergometrine—Hypotension—Irinotecan—stomach cancer	0.00206	0.00502	CcSEcCtD
Methylergometrine—Cardiac disorder—Docetaxel—stomach cancer	0.00199	0.00485	CcSEcCtD
Methylergometrine—Paraesthesia—Irinotecan—stomach cancer	0.00198	0.00483	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Doxorubicin—stomach cancer	0.00197	0.00481	CcSEcCtD
Methylergometrine—Hypotension—Fluorouracil—stomach cancer	0.00197	0.00481	CcSEcCtD
Methylergometrine—Dyspnoea—Irinotecan—stomach cancer	0.00196	0.00479	CcSEcCtD
Methylergometrine—Tinnitus—Capecitabine—stomach cancer	0.00193	0.00472	CcSEcCtD
Methylergometrine—Cardiac disorder—Capecitabine—stomach cancer	0.00193	0.0047	CcSEcCtD
Methylergometrine—Paraesthesia—Fluorouracil—stomach cancer	0.00189	0.00462	CcSEcCtD
Methylergometrine—Dyspnoea—Fluorouracil—stomach cancer	0.00188	0.00459	CcSEcCtD
Methylergometrine—HTR2A—hematopoietic system—stomach cancer	0.00185	0.0294	CbGeAlD
Methylergometrine—Gastrointestinal pain—Irinotecan—stomach cancer	0.0018	0.0044	CcSEcCtD
Methylergometrine—Muscle spasms—Docetaxel—stomach cancer	0.00179	0.00438	CcSEcCtD
Methylergometrine—Angina pectoris—Epirubicin—stomach cancer	0.00176	0.00429	CcSEcCtD
Methylergometrine—Abdominal pain—Irinotecan—stomach cancer	0.00174	0.00425	CcSEcCtD
Methylergometrine—Muscle spasms—Capecitabine—stomach cancer	0.00174	0.00424	CcSEcCtD
Methylergometrine—CYP3A4—hematopoietic system—stomach cancer	0.00171	0.0273	CbGeAlD
Methylergometrine—HTR2A—epithelium—stomach cancer	0.00169	0.0269	CbGeAlD
Methylergometrine—Palpitations—Docetaxel—stomach cancer	0.00165	0.00402	CcSEcCtD
Methylergometrine—Haematuria—Methotrexate—stomach cancer	0.00164	0.004	CcSEcCtD
Methylergometrine—HTR2A—smooth muscle tissue—stomach cancer	0.00163	0.0259	CbGeAlD
Methylergometrine—Angina pectoris—Doxorubicin—stomach cancer	0.00163	0.00397	CcSEcCtD
Methylergometrine—Convulsion—Docetaxel—stomach cancer	0.00162	0.00394	CcSEcCtD
Methylergometrine—Hypertension—Docetaxel—stomach cancer	0.00161	0.00393	CcSEcCtD
Methylergometrine—Palpitations—Capecitabine—stomach cancer	0.0016	0.0039	CcSEcCtD
Methylergometrine—Chest pain—Docetaxel—stomach cancer	0.00159	0.00388	CcSEcCtD
Methylergometrine—Hypertension—Capecitabine—stomach cancer	0.00156	0.00381	CcSEcCtD
Methylergometrine—Chest pain—Capecitabine—stomach cancer	0.00154	0.00375	CcSEcCtD
Methylergometrine—Haematuria—Epirubicin—stomach cancer	0.00154	0.00375	CcSEcCtD
Methylergometrine—Anaphylactic shock—Docetaxel—stomach cancer	0.00152	0.00372	CcSEcCtD
Methylergometrine—Diarrhoea—Irinotecan—stomach cancer	0.00151	0.00368	CcSEcCtD
Methylergometrine—Nervous system disorder—Docetaxel—stomach cancer	0.00149	0.00364	CcSEcCtD
Methylergometrine—Tachycardia—Docetaxel—stomach cancer	0.00149	0.00363	CcSEcCtD
Methylergometrine—Bradycardia—Epirubicin—stomach cancer	0.00147	0.00359	CcSEcCtD
Methylergometrine—Dizziness—Irinotecan—stomach cancer	0.00146	0.00355	CcSEcCtD
Methylergometrine—Nervous system disorder—Capecitabine—stomach cancer	0.00145	0.00353	CcSEcCtD
Methylergometrine—Diarrhoea—Fluorouracil—stomach cancer	0.00144	0.00352	CcSEcCtD
Methylergometrine—Tinnitus—Methotrexate—stomach cancer	0.00144	0.00351	CcSEcCtD
Methylergometrine—Tachycardia—Capecitabine—stomach cancer	0.00144	0.00351	CcSEcCtD
Methylergometrine—Cardiac disorder—Methotrexate—stomach cancer	0.00143	0.0035	CcSEcCtD
Methylergometrine—Hyperhidrosis—Capecitabine—stomach cancer	0.00143	0.00348	CcSEcCtD
Methylergometrine—Hypotension—Docetaxel—stomach cancer	0.00142	0.00347	CcSEcCtD
Methylergometrine—Haematuria—Doxorubicin—stomach cancer	0.00142	0.00347	CcSEcCtD
Methylergometrine—Vomiting—Irinotecan—stomach cancer	0.0014	0.00342	CcSEcCtD
Methylergometrine—Dizziness—Fluorouracil—stomach cancer	0.00139	0.0034	CcSEcCtD
Methylergometrine—Rash—Irinotecan—stomach cancer	0.00139	0.00339	CcSEcCtD
Methylergometrine—Dermatitis—Irinotecan—stomach cancer	0.00139	0.00339	CcSEcCtD
Methylergometrine—Headache—Irinotecan—stomach cancer	0.00138	0.00337	CcSEcCtD
Methylergometrine—Hypotension—Capecitabine—stomach cancer	0.00138	0.00336	CcSEcCtD
Methylergometrine—HTR2B—lymph node—stomach cancer	0.00138	0.0219	CbGeAlD
Methylergometrine—Paraesthesia—Docetaxel—stomach cancer	0.00137	0.00334	CcSEcCtD
Methylergometrine—Bradycardia—Doxorubicin—stomach cancer	0.00136	0.00332	CcSEcCtD
Methylergometrine—Dyspnoea—Docetaxel—stomach cancer	0.00136	0.00331	CcSEcCtD
Methylergometrine—Tinnitus—Epirubicin—stomach cancer	0.00135	0.00329	CcSEcCtD
Methylergometrine—Cardiac disorder—Epirubicin—stomach cancer	0.00134	0.00327	CcSEcCtD
Methylergometrine—Vomiting—Fluorouracil—stomach cancer	0.00134	0.00327	CcSEcCtD
Methylergometrine—Rash—Fluorouracil—stomach cancer	0.00133	0.00325	CcSEcCtD
Methylergometrine—Dermatitis—Fluorouracil—stomach cancer	0.00133	0.00324	CcSEcCtD
Methylergometrine—Paraesthesia—Capecitabine—stomach cancer	0.00132	0.00323	CcSEcCtD
Methylergometrine—Headache—Fluorouracil—stomach cancer	0.00132	0.00323	CcSEcCtD
Methylergometrine—Dyspnoea—Capecitabine—stomach cancer	0.00131	0.00321	CcSEcCtD
Methylergometrine—Nausea—Irinotecan—stomach cancer	0.00131	0.00319	CcSEcCtD
Methylergometrine—HTR2A—digestive system—stomach cancer	0.00129	0.0205	CbGeAlD
Methylergometrine—Nausea—Fluorouracil—stomach cancer	0.00125	0.00306	CcSEcCtD
Methylergometrine—Tinnitus—Doxorubicin—stomach cancer	0.00125	0.00304	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Docetaxel—stomach cancer	0.00125	0.00304	CcSEcCtD
Methylergometrine—Cardiac disorder—Doxorubicin—stomach cancer	0.00124	0.00303	CcSEcCtD
Methylergometrine—Muscle spasms—Epirubicin—stomach cancer	0.00121	0.00295	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Capecitabine—stomach cancer	0.00121	0.00294	CcSEcCtD
Methylergometrine—Abdominal pain—Docetaxel—stomach cancer	0.0012	0.00294	CcSEcCtD
Methylergometrine—CYP3A4—digestive system—stomach cancer	0.00119	0.019	CbGeAlD
Methylergometrine—Abdominal pain—Capecitabine—stomach cancer	0.00117	0.00284	CcSEcCtD
Methylergometrine—Convulsion—Methotrexate—stomach cancer	0.00116	0.00284	CcSEcCtD
Methylergometrine—Chest pain—Methotrexate—stomach cancer	0.00114	0.00279	CcSEcCtD
Methylergometrine—Muscle spasms—Doxorubicin—stomach cancer	0.00112	0.00273	CcSEcCtD
Methylergometrine—Palpitations—Epirubicin—stomach cancer	0.00111	0.00271	CcSEcCtD
Methylergometrine—Anaphylactic shock—Methotrexate—stomach cancer	0.0011	0.00268	CcSEcCtD
Methylergometrine—Convulsion—Epirubicin—stomach cancer	0.00109	0.00266	CcSEcCtD
Methylergometrine—Hypertension—Epirubicin—stomach cancer	0.00109	0.00265	CcSEcCtD
Methylergometrine—Nervous system disorder—Methotrexate—stomach cancer	0.00108	0.00263	CcSEcCtD
Methylergometrine—Chest pain—Epirubicin—stomach cancer	0.00107	0.00261	CcSEcCtD
Methylergometrine—HTR2A—endocrine gland—stomach cancer	0.00106	0.0169	CbGeAlD
Methylergometrine—Hyperhidrosis—Methotrexate—stomach cancer	0.00106	0.00259	CcSEcCtD
Methylergometrine—Diarrhoea—Docetaxel—stomach cancer	0.00104	0.00254	CcSEcCtD
Methylergometrine—Palpitations—Doxorubicin—stomach cancer	0.00103	0.00251	CcSEcCtD
Methylergometrine—Anaphylactic shock—Epirubicin—stomach cancer	0.00103	0.00251	CcSEcCtD
Methylergometrine—Hypotension—Methotrexate—stomach cancer	0.00103	0.0025	CcSEcCtD
Methylergometrine—Convulsion—Doxorubicin—stomach cancer	0.00101	0.00246	CcSEcCtD
Methylergometrine—Diarrhoea—Capecitabine—stomach cancer	0.00101	0.00246	CcSEcCtD
Methylergometrine—Nervous system disorder—Epirubicin—stomach cancer	0.00101	0.00246	CcSEcCtD
Methylergometrine—Dizziness—Docetaxel—stomach cancer	0.00101	0.00246	CcSEcCtD
Methylergometrine—Hypertension—Doxorubicin—stomach cancer	0.00101	0.00245	CcSEcCtD
Methylergometrine—Tachycardia—Epirubicin—stomach cancer	0.001	0.00245	CcSEcCtD
Methylergometrine—Hyperhidrosis—Epirubicin—stomach cancer	0.000993	0.00242	CcSEcCtD
Methylergometrine—Chest pain—Doxorubicin—stomach cancer	0.000991	0.00242	CcSEcCtD
Methylergometrine—Paraesthesia—Methotrexate—stomach cancer	0.000985	0.0024	CcSEcCtD
Methylergometrine—CYP3A4—endocrine gland—stomach cancer	0.000984	0.0157	CbGeAlD
Methylergometrine—Dyspnoea—Methotrexate—stomach cancer	0.000978	0.00239	CcSEcCtD
Methylergometrine—Dizziness—Capecitabine—stomach cancer	0.000975	0.00238	CcSEcCtD
Methylergometrine—Vomiting—Docetaxel—stomach cancer	0.000968	0.00236	CcSEcCtD
Methylergometrine—Rash—Docetaxel—stomach cancer	0.00096	0.00234	CcSEcCtD
Methylergometrine—Hypotension—Epirubicin—stomach cancer	0.00096	0.00234	CcSEcCtD
Methylergometrine—Dermatitis—Docetaxel—stomach cancer	0.000959	0.00234	CcSEcCtD
Methylergometrine—HTR2A—liver—stomach cancer	0.000958	0.0153	CbGeAlD
Methylergometrine—Headache—Docetaxel—stomach cancer	0.000954	0.00233	CcSEcCtD
Methylergometrine—Anaphylactic shock—Doxorubicin—stomach cancer	0.00095	0.00232	CcSEcCtD
Methylergometrine—Vomiting—Capecitabine—stomach cancer	0.000937	0.00229	CcSEcCtD
Methylergometrine—Nervous system disorder—Doxorubicin—stomach cancer	0.000932	0.00227	CcSEcCtD
Methylergometrine—Rash—Capecitabine—stomach cancer	0.000929	0.00227	CcSEcCtD
Methylergometrine—Dermatitis—Capecitabine—stomach cancer	0.000929	0.00227	CcSEcCtD
Methylergometrine—Tachycardia—Doxorubicin—stomach cancer	0.000927	0.00226	CcSEcCtD
Methylergometrine—Headache—Capecitabine—stomach cancer	0.000923	0.00225	CcSEcCtD
Methylergometrine—Paraesthesia—Epirubicin—stomach cancer	0.000922	0.00225	CcSEcCtD
Methylergometrine—Hyperhidrosis—Doxorubicin—stomach cancer	0.000919	0.00224	CcSEcCtD
Methylergometrine—Dyspnoea—Epirubicin—stomach cancer	0.000916	0.00223	CcSEcCtD
Methylergometrine—Nausea—Docetaxel—stomach cancer	0.000904	0.00221	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Methotrexate—stomach cancer	0.000897	0.00219	CcSEcCtD
Methylergometrine—Hypotension—Doxorubicin—stomach cancer	0.000888	0.00217	CcSEcCtD
Methylergometrine—CYP3A4—liver—stomach cancer	0.000887	0.0141	CbGeAlD
Methylergometrine—Nausea—Capecitabine—stomach cancer	0.000876	0.00214	CcSEcCtD
Methylergometrine—Abdominal pain—Methotrexate—stomach cancer	0.000867	0.00212	CcSEcCtD
Methylergometrine—Paraesthesia—Doxorubicin—stomach cancer	0.000853	0.00208	CcSEcCtD
Methylergometrine—Dyspnoea—Doxorubicin—stomach cancer	0.000847	0.00207	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Epirubicin—stomach cancer	0.00084	0.00205	CcSEcCtD
Methylergometrine—Abdominal pain—Epirubicin—stomach cancer	0.000812	0.00198	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000777	0.0019	CcSEcCtD
Methylergometrine—Abdominal pain—Doxorubicin—stomach cancer	0.000751	0.00183	CcSEcCtD
Methylergometrine—Diarrhoea—Methotrexate—stomach cancer	0.000751	0.00183	CcSEcCtD
Methylergometrine—Dizziness—Methotrexate—stomach cancer	0.000726	0.00177	CcSEcCtD
Methylergometrine—Diarrhoea—Epirubicin—stomach cancer	0.000703	0.00171	CcSEcCtD
Methylergometrine—Vomiting—Methotrexate—stomach cancer	0.000698	0.0017	CcSEcCtD
Methylergometrine—Rash—Methotrexate—stomach cancer	0.000692	0.00169	CcSEcCtD
Methylergometrine—Dermatitis—Methotrexate—stomach cancer	0.000691	0.00169	CcSEcCtD
Methylergometrine—Headache—Methotrexate—stomach cancer	0.000687	0.00168	CcSEcCtD
Methylergometrine—Dizziness—Epirubicin—stomach cancer	0.000679	0.00166	CcSEcCtD
Methylergometrine—Vomiting—Epirubicin—stomach cancer	0.000653	0.00159	CcSEcCtD
Methylergometrine—Nausea—Methotrexate—stomach cancer	0.000652	0.00159	CcSEcCtD
Methylergometrine—Diarrhoea—Doxorubicin—stomach cancer	0.00065	0.00159	CcSEcCtD
Methylergometrine—Rash—Epirubicin—stomach cancer	0.000648	0.00158	CcSEcCtD
Methylergometrine—Dermatitis—Epirubicin—stomach cancer	0.000647	0.00158	CcSEcCtD
Methylergometrine—Headache—Epirubicin—stomach cancer	0.000643	0.00157	CcSEcCtD
Methylergometrine—Dizziness—Doxorubicin—stomach cancer	0.000628	0.00153	CcSEcCtD
Methylergometrine—Nausea—Epirubicin—stomach cancer	0.00061	0.00149	CcSEcCtD
Methylergometrine—Vomiting—Doxorubicin—stomach cancer	0.000604	0.00147	CcSEcCtD
Methylergometrine—Rash—Doxorubicin—stomach cancer	0.000599	0.00146	CcSEcCtD
Methylergometrine—Dermatitis—Doxorubicin—stomach cancer	0.000599	0.00146	CcSEcCtD
Methylergometrine—Headache—Doxorubicin—stomach cancer	0.000595	0.00145	CcSEcCtD
Methylergometrine—Nausea—Doxorubicin—stomach cancer	0.000564	0.00138	CcSEcCtD
Methylergometrine—HTR2A—Signaling Pathways—RPS6—stomach cancer	7.82e-05	0.000156	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CA2—stomach cancer	7.8e-05	0.000156	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CXCL8—stomach cancer	7.77e-05	0.000155	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CXCL8—stomach cancer	7.74e-05	0.000154	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ERBB2—stomach cancer	7.73e-05	0.000154	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—HRAS—stomach cancer	7.72e-05	0.000154	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FYN—stomach cancer	7.71e-05	0.000154	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PRKCB—stomach cancer	7.69e-05	0.000153	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—FGFR2—stomach cancer	7.68e-05	0.000153	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6ST—stomach cancer	7.66e-05	0.000153	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADRB2—stomach cancer	7.64e-05	0.000152	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PGAM1—stomach cancer	7.6e-05	0.000152	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NT5E—stomach cancer	7.6e-05	0.000152	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CDKN1B—stomach cancer	7.59e-05	0.000151	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PPP2R1A—stomach cancer	7.48e-05	0.000149	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—IL6—stomach cancer	7.39e-05	0.000147	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CXCL8—stomach cancer	7.33e-05	0.000146	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CXCL8—stomach cancer	7.3e-05	0.000146	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—HRAS—stomach cancer	7.28e-05	0.000145	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALDH7A1—stomach cancer	7.25e-05	0.000145	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PLCE1—stomach cancer	7.25e-05	0.000145	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CCND1—stomach cancer	7.24e-05	0.000144	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—FGFR2—stomach cancer	7.24e-05	0.000144	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—JUN—stomach cancer	7.23e-05	0.000144	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HBEGF—stomach cancer	7.19e-05	0.000143	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CDKN1B—stomach cancer	7.16e-05	0.000143	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—RHOA—stomach cancer	7.11e-05	0.000142	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MMP9—stomach cancer	7.03e-05	0.00014	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IRS2—stomach cancer	7.03e-05	0.00014	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CDKN1A—stomach cancer	7e-05	0.00014	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—IL6—stomach cancer	6.97e-05	0.000139	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—UMPS—stomach cancer	6.95e-05	0.000139	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SMAD4—stomach cancer	6.95e-05	0.000139	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CXCL8—stomach cancer	6.88e-05	0.000137	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6R—stomach cancer	6.84e-05	0.000136	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MAPK8—stomach cancer	6.84e-05	0.000136	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CCND1—stomach cancer	6.83e-05	0.000136	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CAV1—stomach cancer	6.82e-05	0.000136	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—JUN—stomach cancer	6.82e-05	0.000136	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—RHOA—stomach cancer	6.8e-05	0.000136	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—APOA1—stomach cancer	6.8e-05	0.000136	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MMP9—stomach cancer	6.63e-05	0.000132	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADRB2—stomach cancer	6.63e-05	0.000132	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IRS2—stomach cancer	6.63e-05	0.000132	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CDKN1A—stomach cancer	6.61e-05	0.000132	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FYN—stomach cancer	6.6e-05	0.000132	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PPP2R1A—stomach cancer	6.5e-05	0.00013	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PRKCB—stomach cancer	6.49e-05	0.000129	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PDHA1—stomach cancer	6.47e-05	0.000129	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ECHS1—stomach cancer	6.47e-05	0.000129	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6ST—stomach cancer	6.46e-05	0.000129	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MAPK8—stomach cancer	6.45e-05	0.000129	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CAV1—stomach cancer	6.43e-05	0.000128	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—APOA1—stomach cancer	6.41e-05	0.000128	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—VEGFA—stomach cancer	6.31e-05	0.000126	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—STAT3—stomach cancer	6.25e-05	0.000125	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCL8—stomach cancer	6.24e-05	0.000124	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—APC—stomach cancer	6.21e-05	0.000124	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—FGFR2—stomach cancer	6.19e-05	0.000123	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—RHOA—stomach cancer	6.18e-05	0.000123	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PRKCB—stomach cancer	6.12e-05	0.000122	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6ST—stomach cancer	6.09e-05	0.000122	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TYMP—stomach cancer	6.08e-05	0.000121	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—FADS1—stomach cancer	6.08e-05	0.000121	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SMAD4—stomach cancer	6.03e-05	0.00012	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MAPK3—stomach cancer	5.97e-05	0.000119	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCL8—stomach cancer	5.97e-05	0.000119	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—VEGFA—stomach cancer	5.95e-05	0.000119	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—MAPK3—stomach cancer	5.95e-05	0.000119	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—STAT3—stomach cancer	5.9e-05	0.000118	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—APC—stomach cancer	5.85e-05	0.000117	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MYC—stomach cancer	5.81e-05	0.000116	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6R—stomach cancer	5.76e-05	0.000115	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FYN—stomach cancer	5.73e-05	0.000114	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SREBF2—stomach cancer	5.69e-05	0.000114	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—MAPK1—stomach cancer	5.68e-05	0.000113	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—EGFR—stomach cancer	5.68e-05	0.000113	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IRS2—stomach cancer	5.67e-05	0.000113	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—MAPK1—stomach cancer	5.66e-05	0.000113	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—EGFR—stomach cancer	5.66e-05	0.000113	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MAPK3—stomach cancer	5.63e-05	0.000112	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—RORA—stomach cancer	5.62e-05	0.000112	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—MAPK3—stomach cancer	5.61e-05	0.000112	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CAV1—stomach cancer	5.5e-05	0.00011	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—APOA1—stomach cancer	5.49e-05	0.000109	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MYC—stomach cancer	5.48e-05	0.000109	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6R—stomach cancer	5.44e-05	0.000108	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCL8—stomach cancer	5.42e-05	0.000108	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—PIK3CA—stomach cancer	5.41e-05	0.000108	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—SERPINE1—stomach cancer	5.4e-05	0.000108	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—FGFR2—stomach cancer	5.38e-05	0.000107	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—KRAS—stomach cancer	5.37e-05	0.000107	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—MAPK1—stomach cancer	5.36e-05	0.000107	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—EGFR—stomach cancer	5.36e-05	0.000107	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—KRAS—stomach cancer	5.34e-05	0.000107	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—MAPK1—stomach cancer	5.34e-05	0.000106	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—EGFR—stomach cancer	5.33e-05	0.000106	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALDOB—stomach cancer	5.27e-05	0.000105	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PRKCB—stomach cancer	5.23e-05	0.000104	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6ST—stomach cancer	5.21e-05	0.000104	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RHOA—stomach cancer	5.21e-05	0.000104	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—NOS3—stomach cancer	5.15e-05	0.000103	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—PIK3CA—stomach cancer	5.1e-05	0.000102	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—SERPINE1—stomach cancer	5.09e-05	0.000102	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—KRAS—stomach cancer	5.06e-05	0.000101	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—KRAS—stomach cancer	5.04e-05	0.0001	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—APC—stomach cancer	5.01e-05	9.99e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—PIK3CA—stomach cancer	4.93e-05	9.83e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IRS2—stomach cancer	4.92e-05	9.82e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RHOA—stomach cancer	4.91e-05	9.79e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—PIK3CA—stomach cancer	4.91e-05	9.79e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALOX5—stomach cancer	4.9e-05	9.77e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—NOS3—stomach cancer	4.86e-05	9.69e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—DPYD—stomach cancer	4.82e-05	9.61e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ERBB2—stomach cancer	4.82e-05	9.61e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—MAPK3—stomach cancer	4.8e-05	9.57e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CAV1—stomach cancer	4.78e-05	9.52e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—TP53—stomach cancer	4.77e-05	9.51e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APOA1—stomach cancer	4.76e-05	9.5e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PIK3CA—stomach cancer	4.65e-05	9.27e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6R—stomach cancer	4.65e-05	9.27e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—PIK3CA—stomach cancer	4.63e-05	9.23e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCL8—stomach cancer	4.57e-05	9.12e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—MAPK1—stomach cancer	4.56e-05	9.1e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—EGFR—stomach cancer	4.56e-05	9.1e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—HRAS—stomach cancer	4.56e-05	9.1e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ERBB2—stomach cancer	4.55e-05	9.06e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PRKCB—stomach cancer	4.55e-05	9.06e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—HRAS—stomach cancer	4.54e-05	9.06e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6ST—stomach cancer	4.53e-05	9.03e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—TP53—stomach cancer	4.5e-05	8.97e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CDKN1B—stomach cancer	4.46e-05	8.9e-05	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—IL6—stomach cancer	4.37e-05	8.71e-05	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—PIK3CA—stomach cancer	4.36e-05	8.7e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—SERPINE1—stomach cancer	4.36e-05	8.68e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—APC—stomach cancer	4.35e-05	8.67e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—IL6—stomach cancer	4.35e-05	8.67e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCL8—stomach cancer	4.31e-05	8.6e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—KRAS—stomach cancer	4.31e-05	8.6e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—HRAS—stomach cancer	4.3e-05	8.58e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—HRAS—stomach cancer	4.28e-05	8.54e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTT1—stomach cancer	4.26e-05	8.5e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CCND1—stomach cancer	4.26e-05	8.49e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—JUN—stomach cancer	4.25e-05	8.47e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CYP2A6—stomach cancer	4.21e-05	8.4e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CDKN1B—stomach cancer	4.21e-05	8.4e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RHOA—stomach cancer	4.2e-05	8.38e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—MAPK3—stomach cancer	4.17e-05	8.31e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—NOS3—stomach cancer	4.16e-05	8.29e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MMP9—stomach cancer	4.14e-05	8.25e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CDKN1A—stomach cancer	4.12e-05	8.22e-05	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—IL6—stomach cancer	4.12e-05	8.21e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—IL6—stomach cancer	4.1e-05	8.17e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AKR1C3—stomach cancer	4.1e-05	8.17e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6R—stomach cancer	4.04e-05	8.05e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MAPK8—stomach cancer	4.02e-05	8.02e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CCND1—stomach cancer	4.02e-05	8.01e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—JUN—stomach cancer	4.01e-05	7.99e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ENO1—stomach cancer	3.99e-05	7.97e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—MAPK1—stomach cancer	3.96e-05	7.9e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—EGFR—stomach cancer	3.96e-05	7.9e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—PIK3CA—stomach cancer	3.96e-05	7.9e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MMP9—stomach cancer	3.9e-05	7.78e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ERBB2—stomach cancer	3.89e-05	7.75e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CDKN1A—stomach cancer	3.89e-05	7.75e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MAPK8—stomach cancer	3.79e-05	7.56e-05	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—PIK3CA—stomach cancer	3.79e-05	7.55e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—SERPINE1—stomach cancer	3.78e-05	7.54e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—KRAS—stomach cancer	3.74e-05	7.46e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—VEGFA—stomach cancer	3.71e-05	7.4e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL8—stomach cancer	3.69e-05	7.35e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—STAT3—stomach cancer	3.68e-05	7.33e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—HRAS—stomach cancer	3.66e-05	7.31e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RHOA—stomach cancer	3.65e-05	7.27e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—NOS3—stomach cancer	3.61e-05	7.2e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	3.6e-05	7.18e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CD44—stomach cancer	3.54e-05	7.06e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MAPK3—stomach cancer	3.51e-05	7e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—IL6—stomach cancer	3.51e-05	6.99e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—VEGFA—stomach cancer	3.5e-05	6.98e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—STAT3—stomach cancer	3.47e-05	6.91e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—PIK3CA—stomach cancer	3.44e-05	6.86e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CCND1—stomach cancer	3.44e-05	6.85e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—JUN—stomach cancer	3.43e-05	6.84e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MYC—stomach cancer	3.42e-05	6.81e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ERBB2—stomach cancer	3.38e-05	6.73e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—MAPK1—stomach cancer	3.34e-05	6.66e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EGFR—stomach cancer	3.34e-05	6.66e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MMP9—stomach cancer	3.34e-05	6.65e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	3.32e-05	6.63e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MAPK3—stomach cancer	3.31e-05	6.6e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MAPK8—stomach cancer	3.24e-05	6.47e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MYC—stomach cancer	3.22e-05	6.42e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL8—stomach cancer	3.2e-05	6.39e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—HRAS—stomach cancer	3.18e-05	6.34e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—KRAS—stomach cancer	3.16e-05	6.29e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—MAPK1—stomach cancer	3.15e-05	6.28e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EGFR—stomach cancer	3.15e-05	6.28e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CDKN1B—stomach cancer	3.13e-05	6.24e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—IL6—stomach cancer	3.05e-05	6.07e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPP2R1A—stomach cancer	3.01e-05	6.01e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—VEGFA—stomach cancer	3e-05	5.97e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CCND1—stomach cancer	2.98e-05	5.95e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—JUN—stomach cancer	2.98e-05	5.94e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—KRAS—stomach cancer	2.98e-05	5.94e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—STAT3—stomach cancer	2.97e-05	5.91e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTP1—stomach cancer	2.95e-05	5.89e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—HMOX1—stomach cancer	2.91e-05	5.81e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PIK3CA—stomach cancer	2.9e-05	5.78e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MMP9—stomach cancer	2.9e-05	5.78e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CDKN1A—stomach cancer	2.89e-05	5.76e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MAPK3—stomach cancer	2.83e-05	5.65e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAPK8—stomach cancer	2.82e-05	5.62e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—TP53—stomach cancer	2.81e-05	5.59e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MYC—stomach cancer	2.76e-05	5.5e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TYMS—stomach cancer	2.75e-05	5.48e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PIK3CA—stomach cancer	2.73e-05	5.45e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GSTM1—stomach cancer	2.72e-05	5.41e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—MAPK1—stomach cancer	2.7e-05	5.38e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EGFR—stomach cancer	2.7e-05	5.38e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—HRAS—stomach cancer	2.68e-05	5.35e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—TP53—stomach cancer	2.65e-05	5.28e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—VEGFA—stomach cancer	2.6e-05	5.19e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—STAT3—stomach cancer	2.58e-05	5.14e-05	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—IL6—stomach cancer	2.57e-05	5.12e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ERCC2—stomach cancer	2.55e-05	5.09e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—KRAS—stomach cancer	2.55e-05	5.08e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—HRAS—stomach cancer	2.53e-05	5.05e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAPK3—stomach cancer	2.46e-05	4.91e-05	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—IL6—stomach cancer	2.42e-05	4.83e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—MTHFR—stomach cancer	2.4e-05	4.78e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MYC—stomach cancer	2.39e-05	4.77e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—MAPK1—stomach cancer	2.34e-05	4.67e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EGFR—stomach cancer	2.34e-05	4.67e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	2.34e-05	4.67e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—TP53—stomach cancer	2.26e-05	4.51e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CAV1—stomach cancer	2.21e-05	4.41e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—KRAS—stomach cancer	2.21e-05	4.41e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—APOA1—stomach cancer	2.21e-05	4.4e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—HRAS—stomach cancer	2.16e-05	4.32e-05	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—IL6—stomach cancer	2.07e-05	4.13e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PIK3CA—stomach cancer	2.03e-05	4.05e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—TP53—stomach cancer	1.97e-05	3.92e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PPARG—stomach cancer	1.95e-05	3.88e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—HRAS—stomach cancer	1.88e-05	3.75e-05	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—IL6—stomach cancer	1.8e-05	3.59e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ALB—stomach cancer	1.75e-05	3.49e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—NOS3—stomach cancer	1.67e-05	3.34e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PTGS2—stomach cancer	1.53e-05	3.05e-05	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—PIK3CA—stomach cancer	9.42e-06	1.88e-05	CbGpPWpGaD
